ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients. [electronic resource]
Producer: 20180112Description: 4225-35 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Aldehyde Oxidoreductases -- genetics
- Antimetabolites, Antineoplastic -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Biomarkers, Tumor
- Cell Line, Tumor
- Cell Movement -- genetics
- Cell Survival -- genetics
- Cholangiocarcinoma -- diagnosis
- Cisplatin -- pharmacology
- Deoxycytidine -- analogs & derivatives
- Drug Resistance, Neoplasm -- genetics
- Enzyme Activation
- Female
- Gene Knockdown Techniques
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Prognosis
- Protein Isoforms
- Proto-Oncogene Proteins c-met -- genetics
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.